SCHEMBL8107984

SCHEMBL8107984

CC1CCCN(C(=O)c2ccc3nonc3c2)C1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA3 P42263 1/20 0.56
GRIA4 P48058 1/20 0.56
TAS1R3 Q7RTX0 1/20 0.55
TAS1R1 Q7RTX1 1/20 0.55
TAS1R2 Q8TE23 1/20 0.55
ALDH1A1 P00352 5/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HPGD P15428 2/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TRPC3 Q13507 3/20 0.40
TRPC6 Q9Y210 3/20 0.40
LMNA P02545 2/20 0.40
TRPA1 O75762 2/20 0.40
CACNA1C Q13936 2/20 0.40
SCN5A Q14524 2/20 0.40
TRPV1 Q8NER1 2/20 0.40
TRPV4 Q9HBA0 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8107156 0.81 GRIA3 (0.58) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL8108606 0.79 GRIA3 (0.55) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL7900196 0.79 RAB9A (0.55) GRIA3GRIA4KMT2A
SCHEMBL7884908 0.78 GRIA3 (0.54) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL8105521 0.77 GRIA3 (0.59) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL5758784 0.76 GRIA3 (0.70) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL8105886 0.76 GRIA3 (0.52) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL548617 0.75 GRIA3 (0.53) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL8114056 0.75 GRIA3 (0.50) GRIA3GRIA4TAS1R3TAS1R1TAS1R2
SCHEMBL8114060 0.75 GRIA3 (0.50) GRIA3GRIA4TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2233140-A1 Bicyclic amides for enhancing glutamatergic synaptic responses Biovail Laboratories International SRL (BB) 2010-09-29 EP disclosed
WO-2009023126-A2 BICYCLIC AMIDES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2009-02-19 WO disclosed